HOME >> BIOLOGY >> NEWS
New paradigm will help identify leads for drug discovery

Bethesda, Md., Mon., July 24, 2006 -- A new screening approach can profile compounds in large chemical libraries more accurately and precisely than standard methods, speeding the production of data that can be used to probe biological activities and identify leads for drug discovery, the National Institutes of Health (NIH) Chemical Genomics Center, part of the NIH Roadmap for Medical Research's Molecular Libraries and Imaging Initiative, reported today.

"We are excited by the power of this approach, developed through the NIH Roadmap for Medical Research, to generate new chemical 'tools' for biological exploration. These tools will help researchers in both the public and private sectors unlock the mysteries of gene function and signaling pathways throughout the human body, opening the door to the development of new drugs," said NIH Director Elias A. Zerhouni, M.D.

In a paper published online in the Proceedings of the National Academy of Sciences (PNAS), a team from the NIH Chemical Genomics Center demonstrates the feasibility of a new paradigm for profiling every compound in large collections of chemicals. Traditional high-throughput screening measures the biological activity of chemical compounds at just one concentration. In contrast, the new approach, called quantitative high-throughput screening, or qHTS, tests the biological activity of chemical compounds at seven or more concentration levels spanning four orders of magnitude. The multi-concentration screen produces a pharmacological characterization of all the compounds that is far more complete and reliable than traditional methods.

"This advance is crucial to NIH's goal of efficiently profiling the range of biological activities associated with large chemical libraries and making that data swiftly available to the worldwide research community," said Francis S. Collins, M.D., Ph.D., director of the National Human Genome Research Institute (NHGRI). "Broad adoption of this para
'"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
24-Jul-2006


Page: 1 2 3 4

Related biology news :

1. Do we need a paradigm change? Disputing coevolution in herbivorous insects
2. Protein splicing upsets the DNA colinearity paradigm
3. Researcher predicts paradigm shift in heart disease treatment
4. Yale book offers new paradigm for building design
5. Navigating the brain for sense of direction as paradigm for higher cognitive functions
6. Ethical paradigm: Relating embryonic stem cell use to organ donation
7. Research aims to identify markers for menopausal women at risk for deadly blood clot
8. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
9. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
10. U-M researchers identify gene involved in breast cancer
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... Nanomedical Diagnostics , ... new publication titled, “ Graphene-based Biosensor for On-Chip Detection of Bio-Orthogonally Labeled Proteins ... as a “new portable digital device for biosensing… that can be employed for ...
(Date:10/11/2018)... ... October 09, 2018 , ... ? ... market-ready technologies expedite their path to health system adoption and insurer reimbursement, ? ... across all major EHR applications, enabling them to focus on innovation not integration, ...
(Date:10/11/2018)... ... October 11, 2018 , ... ODSC Europe 2018 - ... 100% increase in attendance at the event from September 19-22. , As Europe’s ... intelligence sessions across 10 tracks and 4 days. Attendees were given key insights and ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... (PRWEB) , ... October 02, 2018 , ... ... and Locus Bio-Energy Solutions™, LLC’s (Locus Bio-Energy) AssurEOR product line was chosen for ... Oil and Gulf Energy Information, honor leading innovations in upstream oil applications that ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... this week that teams have initiated validation of standards and testing of procedures ... direction of Dr. Larry Kennedy, ACRES VP for Quality Management Systems and Chief ...
(Date:9/28/2018)... ... September 28, 2018 , ... ... to increase the availability of the GlycoMark test, the only FDA-cleared blood test ... the partnership, PMLS will promote and offer the GlycoMark test to its network ...
(Date:9/27/2018)... ... 26, 2018 , ... NDA Partners Chairman Carl Peck, ... and in vitro diagnostic device expert with more than 28 years of experience ... as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality ...
Breaking Biology Technology:
Cached News: